Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
14.5 MG naltrexone
(D05113)		[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone (D05113) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
2LOW dose naltrexone
(D05113)		----[2] 96, 97 💬
3LOW-dose naltrexone
(D05113)		----[1] 226 💬
4Naltrexone
(D05113)		[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone (D05113) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[5] 6, 10, 13, 96, 226 💬
5Naltrexone cloridrato
(D05113)		[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone (D05113) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 10 💬
6Naltrexone hydrochloride
(D05113)		[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone (D05113) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[9] 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
7Naltrexone-HCL
(D05113)		[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone (D05113) 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 96 💬